Roehrs T, Vogel G, Vogel F, Wittig R, Zorick F, Paxton C, Lamphere J, Roth T
Drugs Exp Clin Res. 1986;12(8):693-9.
The dose effects of temazepam tablets (15 and 30 mg) were studied at two sleep centres in 48 volunteers who had objective polysomnographic evidence of sleep onset insomnia. Volunteers slept in the laboratory, retiring at their usual bedtime after taking placebo or temazepam 30 min earlier, and were monitored for 8 h using standard polysomnographic techniques. Acute (nights 5-7) and short term (nights 11-13) temazepam, both 15 and 30 mg, improved the sleep of these volunteers by reducing sleep latency and increasing sleep time compared to the placebo baseline (nights 2-4). Dose differences were found primarily on the measurement of sleep staging, with 30 mg having a greater or more consistent effect than 15 mg. No residual effects were observed on the basis of questionnaires and objective tests of performance and no consistent evidence of disturbed sleep after discontinuing treatment was seen.
在两个睡眠中心对48名有入睡性失眠客观多导睡眠图证据的志愿者,研究了替马西泮片(15毫克和30毫克)的剂量效应。志愿者在实验室睡觉,比平时就寝时间提前30分钟服用安慰剂或替马西泮后上床睡觉,并使用标准多导睡眠图技术监测8小时。与安慰剂基线(第2 - 4晚)相比,15毫克和30毫克的急性(第5 - 7晚)和短期(第11 - 13晚)替马西泮通过减少睡眠潜伏期和增加睡眠时间改善了这些志愿者的睡眠。剂量差异主要体现在睡眠分期测量上,30毫克的效果比15毫克更大或更一致。根据问卷以及性能客观测试,未观察到残留效应,且停药后未发现持续的睡眠紊乱证据。